A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder	Recruiting	Not stated	2025-11-14		NCT06663358

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chiesi Farmaceutici S.p.A.	24

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory University School of Medicine	Atlanta	United States	47
General Hospital Slovenj Gradec	Slovenj Gradec	Slovenia	1
Infusion Associates	Grand Rapids	United States	3
Lysosomal & Rare Disorder Research & Treatment Center (LRDRTC)	Fairfax	United States	1
Northwestern University - Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	2
Salford Royal	Salford	United Kingdom	1
The Royal Free Hospital	London	United Kingdom	3
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital	Edgbaston	United Kingdom	1
University of Alabama at Birmingham	Birmingham	United States	247
University of Iowa Hospitals and Clinics	Iowa City	United States	99